Real-world Use and Prognosis of Beta Blocker in Patients With Acute Coronary Syndrome in the Central China
CompletedOBSERVATIONAL
Enrollment
3,000
Participants
Timeline
Start Date
March 1, 2017
Primary Completion Date
April 26, 2020
Study Completion Date
April 26, 2020
Conditions
Acute Coronary Syndrome
Trial Locations (1)
450000
Henan province people's hospital, Zhengzhou
All Listed Sponsors
lead
Henan Institute of Cardiovascular Epidemiology
OTHER
NCT03116854 - Real-world Use and Prognosis of Beta Blocker in Patients With Acute Coronary Syndrome in the Central China | Biotech Hunter | Biotech Hunter